Ixazomib and lenalidomide maintenance therapy in multiple myeloma

被引：2
|
作者：
Parrondo, Ricardo D. [1 ]
Alegria, Victoria [1 ]
Roy, Vivek [1 ]
Sher, Taimur [1 ]
Chanan-Khan, Asher A. [1 ]
Ailawadhi, Sikander [1 ]
机构：
[1] Mayo Clin Florida, Deparment Hematol Oncol, Mangurian Bldg,3rd Floor,4500 San Pablo Rd S, Jacksonville, FL 32224 USA
来源：
ANNALS OF HEMATOLOGY | 2021年 / 100卷 / 03期
关键词：
STEM-CELL TRANSPLANTATION;
D O I：
10.1007/s00277-020-04340-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：851 / 853
页数：3
相关论文
共 50 条
  • [1] Ixazomib and lenalidomide maintenance therapy in multiple myeloma
    Ricardo D. Parrondo
    Victoria Alegria
    Vivek Roy
    Taimur Sher
    Asher A. Chanan-Khan
    Sikander Ailawadhi
    [J]. Annals of Hematology, 2021, 100 : 851 - 853
  • [2] Alternating the Administration of Ixazomib and Lenalidomide As Maintenance Therapy after Autologous Transplant for Multiple Myeloma
    Holmberg, Leona A.
    Green, Damian J.
    Lee, Sarah S.
    Cowan, Andrew J.
    [J]. BLOOD, 2022, 140 : 10575 - 10576
  • [3] Oral ixazomib maintenance therapy in multiple myeloma
    Offidani, Massimo
    Corvatta, Laura
    Gentili, Silvia
    Maracci, Laura
    Leoni, Pietro
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (01) : 21 - 32
  • [4] Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma
    Michael Slade
    Thomas G. Martin
    Nitya Nathwani
    Mark A. Fiala
    Michael P. Rettig
    Feng Gao
    Abhinav Deol
    Francis K. Buadi
    Jonathan L. Kaufman
    Craig C. Hofmeister
    Tara K. Gregory
    Jesus Berdeja
    Ajai Chari
    Ashley Rosko
    Ravi Vij
    [J]. Leukemia, 2022, 36 : 2917 - 2921
  • [5] Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma
    Slade, Michael
    Martin, Thomas G.
    Nathwani, Nitya
    Fiala, Mark A.
    Rettig, Michael P.
    Gao, Feng
    Deol, Abhinav
    Buadi, Francis K.
    Kaufman, Jonathan L.
    Hofmeister, Craig C.
    Gregory, Tara K.
    Berdeja, Jesus
    Chari, Ajai
    Rosko, Ashley
    Vij, Ravi
    [J]. LEUKEMIA, 2022, 36 (12) : 2917 - 2921
  • [6] Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Moreau, P.
    Masszi, T.
    Grzasko, N.
    Bahlis, N. J.
    Hansson, M.
    Pour, L.
    Sandhu, I.
    Ganly, P.
    Baker, B. W.
    Jackson, S. R.
    Stoppa, A. -M.
    Simpson, D. R.
    Gimsing, P.
    Palumbo, A.
    Garderet, L.
    Cavo, M.
    Kumar, S.
    Touzeau, C.
    Buadi, F. K.
    Laubach, J. P.
    Berg, D. T.
    Lin, J.
    Di Bacco, A.
    Hui, A. -M.
    van de Velde, H.
    Richardson, P. G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (17): : 1621 - 1634
  • [7] Recommend maintenance therapy with lenalidomide in multiple myeloma
    Manasanch, Elisabet E.
    [J]. SEMINARS IN ONCOLOGY, 2016, 43 (06) : 712 - 713
  • [8] Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma
    Patel, Krina K.
    Shah, Jatin J.
    Feng, Lei
    Lee, Hans C.
    Manasanch, Elisabet M.
    Olsem, Jasper
    Morphey, Ashley
    Huo, Xiao Jiao
    Thomas, Sheeba K.
    Bashir, Qaiser
    Qazilbash, Muzaffar H.
    Weber, Donna M.
    Orlowski, Robert Z.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1277 - 1284
  • [9] Lenalidomide Maintenance Therapy in Patients with Multiple Myeloma
    Fillitz, M.
    Seebacher, A.
    Reisner, R.
    Pittermann-Hocker, E.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S90 - S90
  • [10] Pharmacoeconomic Implications of Lenalidomide Maintenance Therapy in Multiple Myeloma
    Kim, Miriam Y.
    Sposto, Richard
    Swaika, Abhisek
    Asano, Hitomi
    Alamgir, Ahsan
    Chanan-Khan, Asher
    Ailawadhi, Sikander
    [J]. ONCOLOGY, 2014, 87 (04) : 224 - 231
12345